Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Biib074
2. Cnv1014802
3. Vixotrigine
1. 934240-30-9
2. Vixotrigine
3. Cnv1014802
4. Gsk1014802
5. Cnv-1014802
6. Gsk-1014802
7. Biib074
8. Cnv 1014802
9. Biib-074
10. Vixotrigine [usan]
11. Raxatrigine (gsk1014802)
12. (2s,5r)-5-(4-((2-fluorobenzyl)oxy)phenyl)pyrrolidine-2-carboxamide
13. Gsk 1014802
14. Qqs4j85k6y
15. Gsk1014802(cnv1014802)
16. 934240-30-9 (free Base).
17. 2-pyrrolidinecarboxamide, 5-(4-((2-fluorophenyl)methoxy)phenyl)-, (2s,5r)-
18. 2-pyrrolidinecarboxamide, 5-[4-[(2-fluorophenyl)methoxy]phenyl]-, (2s,5r)-
19. Raxatrigine [usan]
20. Gsk2
21. Unii-qqs4j85k6y
22. Biib 074
23. (2s,5r)-5-[4-[(2-fluorophenyl)methoxy]phenyl]pyrrolidine-2-carboxamide
24. (2s,5r)-5-(4-((2-fluorophenyl)methoxy)phenyl)pyrrolidine-2-carboxamide
25. Biib 074,vixotrigine
26. Vixotrigine [inn]
27. Vixotrigine (usan/inn)
28. Vixotrigine [who-dd]
29. Schembl310473
30. Chembl3544913
31. Dtxsid901031867
32. (5r)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-l-prolinamide
33. Ex-a2232
34. Bdbm50505255
35. Zinc34892269
36. Akos027324140
37. Db11706
38. Ncgc00386656-01
39. Ac-31665
40. As-56210
41. Hy-12796
42. Cnv1014802; Gsk-1014802; Raxatrigine
43. D11179
44. N11408
45. A857124
46. (5r)-5-(4-[2-fluorobenzyloxy]phenyl)-l-prolinamide
47. Q18386159
48. (2s,5r)-5-(4-(2-fluorobenzyloxy)phenyl)pyrrolidine-2-carboxamide
49. (5r)-5-{4-[(2-fluorobenzyl)oxy]phenyl}-l-prolinamide;cnv1014802
| Molecular Weight | 314.4 g/mol |
|---|---|
| Molecular Formula | C18H19FN2O2 |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 314.14305602 g/mol |
| Monoisotopic Mass | 314.14305602 g/mol |
| Topological Polar Surface Area | 64.4 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 399 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Vixotrigine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vixotrigine, including repackagers and relabelers. The FDA regulates Vixotrigine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vixotrigine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vixotrigine supplier is an individual or a company that provides Vixotrigine active pharmaceutical ingredient (API) or Vixotrigine finished formulations upon request. The Vixotrigine suppliers may include Vixotrigine API manufacturers, exporters, distributors and traders.
Vixotrigine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vixotrigine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vixotrigine GMP manufacturer or Vixotrigine GMP API supplier for your needs.
A Vixotrigine CoA (Certificate of Analysis) is a formal document that attests to Vixotrigine's compliance with Vixotrigine specifications and serves as a tool for batch-level quality control.
Vixotrigine CoA mostly includes findings from lab analyses of a specific batch. For each Vixotrigine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vixotrigine may be tested according to a variety of international standards, such as European Pharmacopoeia (Vixotrigine EP), Vixotrigine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vixotrigine USP).
LOOKING FOR A SUPPLIER?
